Tvardi Therapeutics, Inc. (TVRD)
NASDAQ·Healthcare·Biotechnology
$3.18
+4.61%
Mkt Cap $37.34M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$4.50
Range $4.00 – $5.00
Implied Upside
+41.5%
Consensus $4.50 vs current $3.18
NASDAQ·Healthcare·Biotechnology
$3.18
+4.61%
Mkt Cap $37.34M
No recent rating data.
Price Target (4 analysts)
$4.50
Range $4.00 – $5.00
+41.5%
Consensus $4.50 vs current $3.18